Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06869694

Energy CT in Imaging and Diagnosis of Gastric Cancer

Accurate preoperative prediction of risk stratification, treatment response, and survival prognosis in gastric cancer is important for improving clinical treatment decisions, prolonging patient survival, and improving patient quality of life. The purpose of this study is to investigate the performance of the multi-parametric magnetic resonance imaging (mpMRI) and Dual-/Muti-energy CT and photon-counting Detector CT(PCD-CT) in the diagnosis and management of gastric cancer.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, China, 450052

Location status: Recruiting

Location contact

Zihao Zhao

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pathological biopsy confirmed gastric cancer;
  • Surgery: patients undergoing radical gastrectomy. Patients undergoing exploratory abdominal surgery or palliative tumor resection were still included in the study when peritoneal metastasis or adjacent organ invasion was identified intraoperatively and radical surgical resection was not possible.

Exclusion criteria

  • Refusal or inability to sign informed consent;
  • CT or MRI images are poor or the focus is small and CT images are not clear;
  • Patients with other tumors complicated with patients with important organ dysfunction.

Treatment and study plan

computerized tomography

Device

mpMRI and Photon-counting Detector CT scan

Primary outcomes

  1. Diagnostic and Predictive performance of Dual-/ Muti- energy CT and MRI in the treatment response and survival prognosis of gastric cancer

    Time frame: 3years

    Accuracy for both imaging techniques in the prediction of treatment response of gastric cancer.

Secondary outcomes

  1. The kappa value; One-way analysis of variance; ICC

    Time frame: 1year

    Consistency of the Photon-counting Detector CT and mpMRI in tumor assessment

Study contacts

Contact information is provided by the study sponsor or research team.

Zihao Zhao, Dr

CONTACT

[email protected]

0371-66271387

Sponsors and collaborators

Lead sponsor

The First Affiliated Hospital of Zhengzhou University

Other

Registry information

Official study title

Diagnostic and Predictive Performance of Dual-/ Muti- Energy CT and MRI in the Treatment Response and Survival Prognosis of Gastric Cancer

Acronym: CTIDGC

Important dates

Study start
2024
Primary completion
2026
Study completion
2028
First posted
Mar 11, 2025
Registry last updated
Mar 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.